Prescribing practices in opioid agonist treatment and changes in compliance to clinical dosing guidelines in British Columbia, Canada.
Brenda Carolina Guerra-AlejosYouwei YanMegan KurzNishan MudaligeJeong Eun MinFahmida HomayraBohdan NosykPublished in: Addiction (Abingdon, England) (2024)
In British Columbia, Canada, from 2014 to 2021, prescribers of opioid agonist treatment (OAT) appeared to initiate both new and experienced OAT clients at higher doses than guideline recommendations, titrate them more rapidly and maintain clients at higher doses. Take-home dose allowances also gradually increased.